Technical Analysis: BSX has shown strong bullish momentum, with the stock price rising from $64.99 to $65.82 over the past week. The stock is trading above its VWAP of $66.31, indicating sustained buying pressure.
News Impact Analysis:
Analyst Sentiment: Wall Street maintains a strongly bullish stance with 24 "Strong Buys," 1 "Moderate Buy," and 2 "Holds". Raymond James recently raised its price target to $119.
Price Prediction for Next Week (Feb 18-23, 2025): Based on technical indicators and recent momentum:
The stock is likely to continue its upward trajectory based on:
Trading Recommendation: BUY Entry point: Current level ($106.06) Stop loss: $104.50 Take profit: $107.50
The stock shows strong potential for continued upward movement based on positive fundamentals, technical strength, and favorable analyst sentiment. The recent pullback provides a good entry opportunity.
The price of BSX is predicted to go up 13.05%, based on the high correlation periods with NCLH. The similarity of these two price pattern on the periods is 99.25%.
BSX
NCLH
Year
BSX Price Forecast($)
Potential Return(%)
2025
91.500
0.890
2026
120.000
17.230
2027
140.000
36.770
2028
150.000
46.540
2029
150.000
46.540
2030
180.000
75.850
Boston remains one of the top players when it comes to intellectual property in the medical technology arena, which bodes well for its ability to innovate enough to keep up with rivals.
Boston's breadth of products and emphasis on differentiation put the company on firm footing as a supplier to hospitals.
More recent acquisitions have put Boston in the leadership role in several niche markets, including subcutaneous ICDs and pulsed field ablation for atrial fibrillation.
Stifel
2025-02-10
Price Target
$115 → $120
Upside
+13.02%
Barclays
2025-02-10
Price Target
$111 → $118
Upside
+11.13%
Raymond James
2025-02-06
Price Target
$119 → $122
Upside
+16.17%